Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 22, 2008, Pages 5888-5891

  Palchaudhuri, Rahul ^a   Hergenrother, Paul J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Anticancer compound; Anticancer drug; Apoptosis; Cancer; Melanoma; Pro apoptotic

Indexed keywords

AMIDE; TRIPHENYLMETHYLAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CULTURE MEDIUM; DRUG SOLUBILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MELANOMA CELL; STRUCTURE ACTIVITY RELATION;

AMIDES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; G1 PHASE; HUMANS; MELANOMA; MOLECULAR STRUCTURE; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 55249120173     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.07.128     Document Type: Article

References (22)

1. Balch C.M., Buzaid A.C., Soong S.J., Atkins M.B., Cascinelli N., Coit D.G., Fleming I.D., Gershenwald J.E., Houghton Jr. A., Kirkwood J.M., McMasters K.M., Mihm M.F., Morton D.L., Reintgen D.S., Ross M.I., Sober A., Thompson J.A., and Thompson J.F. J. Clin. Oncol. 19 (2001) 3635
2. Lee M.L., Tomsu K., and Von Eschen K.B. Melanoma Res. 10 (2000) 81
3. Riker A.I., Radfar S., Liu S., Wang Y., and Khong H.T. Expert Opin. Biol. Ther. 7 (2007) 345
4. Petrella T., Quirt I., Verma S., Haynes A.E., Charette M., and Bak K. Curr. Oncol. 14 (2007) 21
5. Keilholz U., Punt C.J., Gore M., Kruit W., Patel P., Lienard D., Thomas J., Proebstle T.M., Schmittel A., Schadendorf D., Velu T., Negrier S., Kleeberg U., Lehman F., Suciu S., and Eggermont A.M. J. Clin. Oncol. 23 (2005) 6747
6. Atallah E., and Flaherty L. Curr. Treat. Options Oncol. 6 (2005) 185
7. Soengas M.S., and Lowe S.W. Oncogene 22 (2003) 3138
8. Lage H., Christmann M., Kern M.A., Dietel M., Pick M., Kaina B., and Schadendorf D. Int. J. Cancer 80 (1999) 744
9. Giodini A., Kallio M.J., Wall N.R., Gorbsky G.J., Tognin S., Marchisio P.C., Symons M., and Altieri D.C. Cancer Res. 62 (2002) 2462
10. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Nature 396 (1998) 580
11. Dothager R.S., Putt K.S., Allen B.J., Leslie B.J., Nesterenko V., and Hergenrother P.J. J. Am. Chem. Soc. 127 (2005) 8686
12. Palchaudhuri R., Nesterenko V., and Hergenrother P.J. J. Am. Chem. Soc. 130 (2008) 10274
13. Gao M., Kong D., Clearfield A., Miller K., Sledge G., and Zheng Q.-H. Synthesis (2006) 2301
14. Vichai V., and Kirtikara K. Nat. Protoc. 1 (2006) 1112
15. Natarajan A., Fan Y.H., Chen H., Guo Y., Iyasere J., Harbinski F., Christ W.J., Aktas H., and Halperin J.A. J. Med. Chem. 47 (2004) 1882
16. Penso J., and Beitner R. Eur. J. Pharmacol. 342 (1998) 113
17. Benzaquen L.R., Brugnara C., Byers H.R., Gatton-Celli S., and Halperin J.A. Nat. Med. 1 (1995) 534
18. Wulff H., Gutman G.A., Cahalan M.D., and Chandy K.G. J. Biol. Chem. 276 (2001) 32040
19. Cao M.Y., Lee Y., Feng N.P., Al-Qawasmeh R.A., Viau S., Gu X.P., Lau L., Jin H., Wang M., Vassilakos A., Wright J.A., and Young A.H. J. Pharmacol. Exp. Ther. 308 (2004) 538
20. Skoufias D.A., DeBonis S., Saoudi Y., Lebeau L., Crevel I., Cross R., Wade R.H., Hackney D., and Kozielski F. J. Biol. Chem. 281 (2006) 17559
21. Al-Qawasmeh R.A., Lee Y., Cao M.Y., Gu X., Vassilakos A., Wright J.A., and Young A. Bioorg. Med. Chem. Lett. 14 (2004) 347
22. Ogo N., Oishi S., Matsuno K., Sawada J., Fujii N., and Asai A. Bioorg. Med. Chem. Lett. 17 (2007) 3921